Contract Award For Antineoplastic And Immunomodulating Agents – 2023/0491-Nivolumab [10 Mg/Ml; 4 Ml; Sol Inj; Frs] N160-Nivolumab [10 Mg/Ml; 4 Ml; Sol Inj; Frs]
Key Dates
2025-03-12
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
